IDO1 and hepatocellular carcinoma: In our study, we demonstrated that HSV-1 treatment on HCC cells upregulated IDO1 expression, and IDO1 impaired HSV-1 replication in HCC cells as a negative loop of the immune system to clear the viruses, raising the demand to inhibiting IDO1 during HSV-1-based virotherapy.